ADARx IPO raises $602.5M after underwriters exercise full option Oct 1, 2026 04:15PM
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering Oct 1, 2026 04:15PM
ADARx Pharmaceuticals prices $446.3M IPO at $17 per share Sep 24, 2026 07:33PM
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering Sep 24, 2026 07:33PM
ADARx Pharmaceuticals targets $1.74 billion valuation in US IPO Sep 21, 2026 06:45AM


Sep 14, 2026 05:04PM ADARx Pharmaceuticals (ADRX) files for Nasdaq IPO
Sep 4, 2026 05:28PM ADARx Pharmaceuticals files for proposed IPO